Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Israel Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20071
20085
20092
20101
20113
20122
20133
20141
20151
20163
20172
20183
20192
20201
20216
20222
20232
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated12
Active, not recruiting4
Recruiting4
Unknown status4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion11
United Therapeutics8
Merck Sharp & Dohme LLC5
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA4
Rabin Medical Center3
Aerovate Therapeutics2
Biogen2
Lung Biotechnology PBC2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension50
Hypertension, Pulmonary14
Hypertension6
Cardiovascular Diseases3
Familial Primary Pulmonary Hypertension3
Lung Diseases3
Respiratory Tract Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Adenoviridae Infections1

Trials

Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.